SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Kosan BioSciences -- KOSN -- Ignore unavailable to you. Want to Upgrade?

To: nigel bates who wrote (705)6/7/2006 2:09:28 PM
From: keokalani'nui  Read Replies (1) | Respond to of 933
 
Why do UK biotechs issue so many shares that they trade at double digit pence levels? A theatre ticket costs as much as a round lot of great science.

And by the way, congrats (Neutec).



To: nigel bates who wrote (705)6/9/2006 11:03:21 AM
From: keokalani'nui  Read Replies (2) | Respond to of 933
 
Renovo is indeed a little gem. And a good choice for Neutec profits. At first glance I thought no way.

Thanks for mentioning it.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News